Literature DB >> 7627567

A middle-latency auditory-evoked potential in the rat.

H Miyazato1, R D Skinner, N B Reese, F A Boop, E Garcia-Rill.   

Abstract

Previous studies have established the presence of a middle-latency auditory-evoked potential that is characterized by a) sleep-state dependence, b) low following frequency (i.e., rapid habituation to repetitive stimulation), and c) blockade by the cholinergic antagonist, scopolamine. A vertex-recorded evoked potential having these characteristics was described in humans at a 50-80 ms latency (termed the P1 or.P50 potential) and in the cat at a 20-25 ms latency (termed wave A). These studies were undertaken to determine if a click stimulus-evoked potential having the same characteristics was present in the intact rat. Vertex and auditory cortex recordings in intact rats studied in a sound-attenuating chamber and exposed to free-field click stimuli showed a) the presence of a vertex recorded potential at a 11-15 ms latency, termed P13, and of an auditory cortex recorded potential at a 7-11 ms latency, termed Pa; b) the P13 was present during waking and paradoxical sleep but absent in slow-wave sleep, while Pa was present in all sleep-wake states; c) the P13 habituated markedly at stimulation rates above 1 Hz while Pa did not; and d) the P13 was blocked by low doses of scopolamine while Pa was not. These studies demonstrate the presence of a P1-like potential in the rat at a 13 +/- 2 ms latency.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7627567     DOI: 10.1016/0361-9230(95)00003-w

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  11 in total

1.  State-dependent changes in cortical gain control as measured by auditory evoked responses to varying intensity stimuli.

Authors:  Derrick J Phillips; Jennifer L Schei; Peter C Meighan; David M Rector
Journal:  Sleep       Date:  2011-11-01       Impact factor: 5.849

2.  Nicotine suppresses the P13 auditory evoked potential by acting on the pedunculopontine nucleus in the rat.

Authors:  N Mamiya; R Buchanan; T Wallace; R D Skinner; E Garcia-Rill
Journal:  Exp Brain Res       Date:  2005-03-08       Impact factor: 1.972

3.  AROUSAL FROM SLICES TO HUMANS: Translational studies on sleep-wake control.

Authors:  N Kezunovic; C Simon; J Hyde; K Smith; P Beck; A Odle; E Garcia-Rill
Journal:  Transl Neurosci       Date:  2010-03-01       Impact factor: 1.757

Review 4.  The pedunculopontine tegmental nucleus: from basic neuroscience to neurosurgical applications: arousal from slices to humans: implications for DBS.

Authors:  Edgar Garcia-Rill; Christen Simon; Kristen Smith; Nebosja Kezunovic; James Hyde
Journal:  J Neural Transm (Vienna)       Date:  2010-10-09       Impact factor: 3.575

5.  Noradrenergic antagonism of the P13 and N40 components of the rat auditory evoked potential.

Authors:  Sarah K Keedy; Megan Marlow-O'Connor; Beth Beenken; Jill Dorflinger; Marc Abel; Roland J Erwin
Journal:  Psychopharmacology (Berl)       Date:  2006-11-10       Impact factor: 4.530

6.  Modafinil increases arousal determined by P13 potential amplitude: an effect blocked by gap junction antagonists.

Authors:  Paige Beck; Angela Odle; Tiffany Wallace-Huitt; Robert D Skinner; Edgar Garcia-Rill
Journal:  Sleep       Date:  2008-12       Impact factor: 5.849

Review 7.  Pre-attentive processing and schizophrenia: animal studies.

Authors:  Bart A Ellenbroek
Journal:  Psychopharmacology (Berl)       Date:  2003-12-04       Impact factor: 4.530

8.  Effects of glutamate receptor agonists on the p13 auditory evoked potential and startle response in the rat.

Authors:  Christen Simon; Tiffany Wallace-Huitt; Priyenka Thapa; Robert D Skinner; Edgar Garcia-Rill
Journal:  Front Neurol       Date:  2011-01-27       Impact factor: 4.003

9.  State-dependent changes in auditory sensory gating in different cortical areas in rats.

Authors:  Renli Qi; Minghong Li; Yuanye Ma; Nanhui Chen
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

10.  Subcortical evoked activity and motor enhancement in Parkinson's disease.

Authors:  Anam Anzak; Huiling Tan; Alek Pogosyan; Sadaquate Khan; Shazia Javed; Steven S Gill; Keyoumars Ashkan; Harith Akram; Thomas Foltynie; Patricia Limousin; Ludvic Zrinzo; Alexander L Green; Tipu Aziz; Peter Brown
Journal:  Exp Neurol       Date:  2015-12-11       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.